BACKGROUND: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline lowered the BP thresholds for defining hypertension compared with the Seventh Report of the Joint National Committee (JNC7) guideline. METHODS: We analyzed clinic and ambulatory BP monitoring data from 717 Coronary Artery Risk Development in Young Adults study participants and compared the prevalence of clinic and out-of-clinic BP phenotypes using thresholds from the 2017 ACC/AHA and JNC7 guidelines. RESULTS: Among participants not taking antihypertensive medication and according to the JNC7 and 2017 ACC/AHA guidelines, 11.1 and 30.1% of participants had clinic hypertension, 37.5 and 57.9% had awake hypertension, 35.7 and 58.1% had asleep hypertension, and 35.7 and 58.6% had 24-h hypertension, respectively. According to the JNC7 and 2017 ACC/AHA guideline definitions, 1.9 and 3.2% had white-coat hypertension, 28.2 and 31.0% had masked hypertension and 9.3 and 26.9% had sustained hypertension, respectively. Among participants taking antihypertensive medication and when defined using the JNC7 and 2017 ACC/AHA guideline BP thresholds, 18.6 and 45.3% had uncontrolled clinic BP, 48.1 and 62.5% had uncontrolled awake BP, 48.1 and 70.2% had uncontrolled asleep BP and, 47.7 and 65.3% had uncontrolled 24-h BP, respectively. Using JNC7 and 2017 ACC/AHA guideline BP thresholds, the prevalence was 1.4 and 5.2% for white-coat effect, 30.9 and 22.5% for masked uncontrolled hypertension, and 17.2 and 40.0% for sustained uncontrolled BP, respectively. CONCLUSION: The 2017 ACC/AHA guideline results in a substantially higher prevalence of awake, asleep, 24-h, and sustained hypertension.
BACKGROUND: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline lowered the BP thresholds for defining hypertension compared with the Seventh Report of the Joint National Committee (JNC7) guideline. METHODS: We analyzed clinic and ambulatory BP monitoring data from 717 Coronary Artery Risk Development in Young Adults study participants and compared the prevalence of clinic and out-of-clinic BP phenotypes using thresholds from the 2017 ACC/AHA and JNC7 guidelines. RESULTS: Among participants not taking antihypertensive medication and according to the JNC7 and 2017 ACC/AHA guidelines, 11.1 and 30.1% of participants had clinic hypertension, 37.5 and 57.9% had awake hypertension, 35.7 and 58.1% had asleep hypertension, and 35.7 and 58.6% had 24-h hypertension, respectively. According to the JNC7 and 2017 ACC/AHA guideline definitions, 1.9 and 3.2% had white-coat hypertension, 28.2 and 31.0% had masked hypertension and 9.3 and 26.9% had sustained hypertension, respectively. Among participants taking antihypertensive medication and when defined using the JNC7 and 2017 ACC/AHA guideline BP thresholds, 18.6 and 45.3% had uncontrolled clinic BP, 48.1 and 62.5% had uncontrolled awake BP, 48.1 and 70.2% had uncontrolled asleep BP and, 47.7 and 65.3% had uncontrolled 24-h BP, respectively. Using JNC7 and 2017 ACC/AHA guideline BP thresholds, the prevalence was 1.4 and 5.2% for white-coat effect, 30.9 and 22.5% for masked uncontrolled hypertension, and 17.2 and 40.0% for sustained uncontrolled BP, respectively. CONCLUSION: The 2017 ACC/AHA guideline results in a substantially higher prevalence of awake, asleep, 24-h, and sustained hypertension.
Authors: Telisa Spikes; Raphiel Murden; Izraelle I McKinnon; Samantha Bromfield; Miriam E Van Dyke; Renee H Moore; Frederic F Rahbari-Oskoui; Arshed Quyummi; Viola Vaccarino; Tené T Lewis Journal: JAMA Netw Open Date: 2022-02-01
Authors: Mark K Santillan; Richard C Becker; David A Calhoun; Allen W Cowley; Joseph T Flynn; Justin L Grobe; Theodore A Kotchen; Daniel T Lackland; Kimberly K Leslie; Mingyu Liang; David L Mattson; Kevin E Meyers; Mark M Mitsnefes; Paul M Muntner; Gary L Pierce; Jennifer S Pollock; Curt D Sigmund; Stephen J Thomas; Elaine M Urbina; Srividya Kidambi Journal: Hypertension Date: 2021-05-03 Impact factor: 9.897
Authors: Mariana P de Souza; Paulo Cesar Lopes; Gabriel Bazo; Paulo Ricardo H Rocha; Daniela Aparecida Lorencini; Heloisa Bettiol; Marco Antonio Barbieri; Eduardo B Coelho Journal: Medicine (Baltimore) Date: 2022-02-11 Impact factor: 1.817
Authors: Bharat Poudel; Anthony J Viera; Daichi Shimbo; Joseph E Schwartz; James M Shikany; Swati Sakhuja; Donald M Lloyd-Jones; Paul Muntner; Yuichiro Yano Journal: J Hypertens Date: 2022-07-05 Impact factor: 4.776
Authors: Brandon K Bellows; Jingyu Xu; James P Sheppard; Joseph E Schwartz; Daichi Shimbo; Paul Muntner; Richard J McManus; Andrew E Moran; Kelsey B Bryant; Laura P Cohen; Adam P Bress; Jordan B King; James M Shikany; Beverly B Green; Yuichiro Yano; Donald Clark; Yiyi Zhang Journal: Am J Hypertens Date: 2022-06-16 Impact factor: 3.080